Suma Gopinathan

Novel Class of LIM-Kinase 2 Inhibitors for the Treatment of Ocular Hypertension and Associated Glaucoma

Bryce A. Harrison, N. Andrew Whitlock, Michael Voronkov et al. · Journal of Medicinal Chemistry · 2009 · 77 citations · Full text

Hypertension, Ocular Disease, Ophthalmology +14

Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders

Jeffrey T. Bagdanoff, Michael S. Donoviel, Amr Nouraldeen et al. · Journal of Medicinal Chemistry · 2009 · 74 citations · Full text

Immunology, Cell Death, Immunologic Mechanism +20

Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes

Nicole C. Goodwin, Zhi‐Ming Ding, Bryce A. Harrison et al. · Journal of Medicinal Chemistry · 2017 · 64 citations · Full text

Medicinal Chemistry, Translational Medicine, Diabetes Management +15

Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma

Bryce A. Harrison, Zheng Y. Almstead, Hugh A. Burgoon et al. · ACS Medicinal Chemistry Letters · 2014 · 60 citations · Full text

Hypertension, Ocular Disease, Ophthalmology +14

Genetic Deletion of Mst1 Alters T Cell Function and Protects against Autoimmunity

Konstantin V. Salojin, Brian D. Hamman, Wei Chun Chang et al. · PLoS ONE · 2014 · 47 citations · Full text